New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment ...

Ataluren preserved upper limb function in boys with nonsense mutation Duchenne muscular dystrophy, according to a poster presented at the MDA Clinical & Scientific Conference.

Monitoring Duchenne muscular dystrophy helps ensure timely treatment. Learn what doctors watch for as Duchenne MD progresses.

Muscular dystrophy is the overarching name for a group of illnesses that progressively cause a reduction in muscle mass and ...

WebMD explains the causes, symptoms, and treatment of Duchenne muscular dystrophy, a rare muscle disease that mainly affects mainly boys in early childhood.

We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...

A meta-analysis of 12 studies of Duchenne patients showed a significant difference in muscular strength and endurance favoring exercise training compared with no training and placebo, but the ...

Groundbreaking gene therapy offers hope for a boy with fatal muscular dystrophy, potentially slowing disease progression and allowing him a chance at a normal life.

Duchenne muscular dystrophy – diagnosis, clinical development and global research Its impact on patients, available treatments and why early diagnosis is essential Muscular dystrophy refers to a group ...

A new gene therapy for Duchenne muscular dystrophy (DMD) has shown promise in not only slowing the progression of the disease but potentially even reversing the muscle damage.